Addendum to Letter to the Editor: Safety, Efficacy, and Authorization of Eliglustat as a First-Line Therapy in Gaucher Disease Type 1

AuthID
P-00Q-GK9
26
Author(s)
Mistry, PK
·
Balwani, M
·
Baris, HN
·
Burrow, TA
·
Charrow, J
·
Cox, GF
·
Dragosky, M
·
[+1]·
[+2]·
[+3]·
Petakov, M
·
Rosenbaum, H
·
Rosenbloom, B
·
Underhill, LH
·
Document Type
Letter
Year published
2019
Published
in BLOOD CELLS MOLECULES AND DISEASES, ISSN: 1079-9796
Volume: 77, Pages: 101-102 (2)
Indexing
Publication Identifiers
SCOPUS: 2-s2.0-85064623158
Wos: WOS:000467537900018
Source Identifiers
ISSN: 1079-9796
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Mistry, PK;   2 Balwani, M;   3 Baris, HN;
4 Ben Turkia, H;   5 Burrow, TA;   6 Charrow, J;
7 Cox, GF;   8 Danda, S;   9 Dragosky, M;
10 Drelichman, G;   11 El Beshlawy, A;   12 Fraga, C;
13 Freisens, S;   14 Gaemers, S;   15 Hadjiev, E;
16 Kishnani, PS;   17 Lukina, E;   18 Maison Blanche, P;
19 Martins, AM;   20 Pastores, G;   21 Petakov, M;
22 Peterschmitt, MJ;   23 Rosenbaum, H;   24 Rosenbloom, B;
25 Underhill, LH;   26 Cox, TM;